CVE-2026-78424OS Command Injection in Packet-Capture (Sniffer) Filter leading to Remote Code Execution on Kubernetes Nodes
Updated under an hour ago ()
Does this affect you?
It affects SUSE NeuVector. Add what you run to find out whether that includes you.
EPSS puts the chance of exploitation in the next 30 days at 0.20%, higher than 9% of scored CVEs.
Do this next
Free account, 1 product
Improper parameter handling in NeuVector allows any authenticated user who holds the namespaced Runtime Policies (write) permission or anyone with access to NeuVector’s internal gRPC certificate key pair the ability to inject OS commands in the privileged enforcer container, which can lead to the complete compromise of the worker node. This affects NeuVector 5.4 before 5.4.11, NeuVector 5.5 before 5.5.4, NeuVector 5.6 before 5.6.2 and potentially older versions.
- CVSS
- 8.8 HIGH (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
- Weakness (CWE)
- CWE-78
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- 0.20% (percentile 9)
- Assigned by
- suse
- NVD analysis
- Awaiting Analysis
- Record last updated
- Sep 29, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
SUSE NeuVector suse:neuvector (from the name) | before 5.4.11; from 5.5.0 before 5.5.4; from 5.6.0 before 5.6.2 | CNA record |
References
- https://github.com/neuvector/neuvector/security/advisories/GHSA-vr77-8vmq-qfmjvendor-advisory
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.